National Drug Strategy
National Drug Strategy

National Amphetamine-Type Stimulant Strategy 2008-2011

The National Amphetamine-Type Stimulant Strategy 2008-2011 (the Strategy) has been developed within the existing legislative framework and focuses on prevention, supply reduction and treatment in a partnership framework.

TOC |next page

In May 2006 the Ministerial Council on Drug Strategy (MCDS) agreed to develop a National Amphetamine-Type Stimulant Strategy.

The National Amphetamine-Type Stimulant (ATS) Strategy 2008-2011 is informed by the research literature, scientific evidence, a nationwide consultation process and written submissions from key stakeholders around Australia. It has been developed on behalf of MCDS under the direction of a Project Management Group chaired by Ms Virginia Hart (Assistant Secretary, Drug Strategy Branch, Australian Government Department of Health and Ageing) with input from three supporting reference groups in Law Enforcement, Public Health and Treatment and Research. Project development and research was provided by the National Drug Research Institute (NDRI) (Curtin University of Technology) and the Australian Institute of Criminology (AIC). The Project Team consisted of Professor Steve Allsop, Ms Jessica George and Associate Professor Simon Lenton (NDRI), and Dr Toni Makkai and Dr Jan Baker (AIC). The advice and support of Mr Peter Rogers and Mr Jeremy Williams from the Australian Government Department of Health and Ageing is acknowledged. In particular, the Project Team is indebted to Ms Jenny McLaren from the National Drug and Alcohol Research Centre (NDARC; University of New South Wales) who provided advice on the process used to develop the National Cannabis Strategy 2006-2009.

TOC |next page